Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Vedolizumab yields sustained improvements in fistulizing Crohn’s disease
Intravenous dosing regimens of vedolizumab appear to favourably alter outcomes in patients with fistulizing Crohn’s disease, according to data from the phase IV ENTERPRISE trial.
Vedolizumab yields sustained improvements in fistulizing Crohn’s disease
05 Oct 2021Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis
Collagen proportionate area (CPA) is a good predictor of long-term mortality in alcoholic hepatitis (AH) patients regardless of their abstinence from alcohol, a recent study has found. However, CPA seems to have no clear interaction with short-term mortality.
Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis
04 Oct 2021COVID-19 in childhood cancer patients: What are the risk factors?
A large international database study has shown that children and adolescents with cancer have an elevated risk of severe or critical disease if infected with COVID-19. Furthermore, about half the patients receiving cancer therapy experienced modifications to their treatment regimens.
COVID-19 in childhood cancer patients: What are the risk factors?
04 Oct 2021Singapore lags in latent tuberculosis screening among HIV-positive individuals
Latent tuberculosis (TB) infection screening in Singapore, a nation with intermediate TB burden, appears to be below average among individuals who are HIV-positive, a study has revealed.
Singapore lags in latent tuberculosis screening among HIV-positive individuals
04 Oct 2021Acute abdomen, appendicitis may occur in children with COVID-19, MIS-C
Paediatric patients with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) may develop acute abdomen, with or without appendicitis, a study in Latin America has found.
Acute abdomen, appendicitis may occur in children with COVID-19, MIS-C
04 Oct 2021Varenicline plus naltrexone may aid in smoking cessation, drinking reduction
Varenicline alone is an adequate therapy for smoking cessation in heavy-drinking smokers, but combining it with naltrexone may provide benefits in terms of drinking outcomes, particularly during the 12-week period of active medication treatment, suggests a study.
Varenicline plus naltrexone may aid in smoking cessation, drinking reduction
04 Oct 2021Insomnia persistent in second and third waves of COVID-19 in Hong Kong
Clinical insomnia was reported in one-third of Hong Kong citizens during the third wave of the coronavirus disease 2019 (COVID-19) outbreak, with over 60 percent having persistent insomnia in both the second and third waves, according to a recent longitudinal follow-up study in Hong Kong.